{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:08:10Z","timestamp":1790726890957,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05119-1","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:29:41Z","timestamp":1783330181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consecutive PRES and diffuse alveolar hemorrhage in a patient with active lupus nephritis and antiphospholipid antibodies: a case report and systematic literature review"],"prefix":"10.1186","volume":"27","author":[{"given":"Yagmur","family":"Ersoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda Gul","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Tekgol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Korkmazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevlut Tamer","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Murt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Trabulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"5119_CR1","doi-asserted-by":"publisher","unstructured":"Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update in the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis.2021;80(1):14-25. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218272.","DOI":"10.1136\/annrheumdis-2020-218272"},{"key":"5119_CR2","doi-asserted-by":"publisher","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(3):137-152. https:\/\/doi.org\/10.1038\/s41584-018-0156-8.","DOI":"10.1038\/s41584-018-0156-8"},{"issue":"1","key":"5119_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheumatic Dis. 2024;83(1):15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762.","journal-title":"Ann Rheumatic Dis"},{"issue":"6","key":"5119_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3174\/ajnr.A0928","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, Part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036\u201342. https:\/\/doi.org\/10.3174\/ajnr.A0928.","journal-title":"AJNR Am J Neuroradiol"},{"key":"5119_CR5","doi-asserted-by":"publisher","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608-1616. https:\/\/doi.org\/10.1007\/s00415-016-8377-.","DOI":"10.1007\/s00415-016-8377-"},{"issue":"8","key":"5119_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/0961203319856416","volume":"28","author":"HW Cui","year":"2019","unstructured":"Cui HW, Lei RY, Zhang SG, Han LS, Zhang BA. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study. Lupus. 2019;28(8):961\u201369. https:\/\/doi.org\/10.1177\/0961203319856416.","journal-title":"Lupus"},{"issue":"3","key":"5119_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/jnnp-2014-310145","volume":"87","author":"J Merayo-Chalico","year":"2016","unstructured":"Merayo-Chalico J, Apodaca E, Barrera-Vargas A, Alcocer-Varela J, Colunga-Pedraza I, Gonz\u00e1lez-Pati\u00f1o A, et al. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case\u2013control study. J Neurol, Neurosurg Psychiatry. 2016;87(3):287\u201394. https:\/\/doi.org\/10.1136\/jnnp-2014-310145.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"7","key":"5119_CR8","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1021\/acs.chemrestox.0c00146","volume":"33","author":"K Bein","year":"2020","unstructured":"Bein K, Birru RL, Wells H, Larkin TP, Cantrell PS, Fagerburg MV, et al. Albumin protects lung cells against acrolein cytotoxicity and acrolein-adducted albumin increases heme oxygenase 1 transcripts. Chem Res Toxicol. 2020;33(7):1969\u201379. https:\/\/doi.org\/10.1021\/acs.chemrestox.0c00146.","journal-title":"Chem Res Toxicol"},{"key":"5119_CR9","doi-asserted-by":"crossref","unstructured":"Weening JJ, D\u2019agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited hirofumi Makino. In: Luiz A Moura, and Michio Nagata, on behalf of the International society of nephrology and renal pathology society working group on the classification of Lupus nephritis. Kidney Int. 2004;65(2):521-530.","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"issue":"8","key":"5119_CR10","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/ndt\/gfm278","volume":"22","author":"T Zar","year":"2007","unstructured":"Zar T, Samson W, Palmisano J. Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with systemic lupus erythematosus (SLE) and lupus nephritis. Nephrol Dial Transpl. 2007;22(8):2400\u201301. https:\/\/doi.org\/10.1093\/ndt\/gfm278.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5119_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/0961203307078682","volume":"16","author":"ML Ishimori","year":"2007","unstructured":"Ishimori ML, Pressman BD, Wallace DJ, Weisman MH. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus. 2007;16(6):436\u201343. https:\/\/doi.org\/10.1177\/0961203307078682.","journal-title":"Lupus"},{"issue":"987","key":"5119_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/pgmj.2007.062612","volume":"84","author":"R Sinha","year":"2008","unstructured":"Sinha R, Hurley RM. Posterior reversible encephalopathy syndrome in SLE nephritis. Postgrad Med J. 2008;84(987):56. https:\/\/doi.org\/10.1136\/pgmj.2007.062612.","journal-title":"Postgrad Med J"},{"issue":"2","key":"5119_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ndt\/gfm811","volume":"23","author":"K Karoui","year":"2007","unstructured":"Karoui K, le Quintrec M, Dekeyser E, Servais A, Hummel A, Fadel F, et al. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Nephrol Dial Transpl. 2007;23(2):757\u201363. https:\/\/doi.org\/10.1093\/ndt\/gfm811.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"5119_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2169\/internalmedicine.47.0741","volume":"47","author":"YX Zhang","year":"2008","unstructured":"Zhang YX, Liu JR, Ding MP, Huang J, Zhang M, Jansen O, et al. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med. 2008;47(9):867\u201375. https:\/\/doi.org\/10.2169\/internalmedicine.47.0741.","journal-title":"Intern Med"},{"issue":"2","key":"5119_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0961203307085405","volume":"17","author":"G Leroux","year":"2008","unstructured":"Leroux G, Sellam J, Costedoat-Chalumeau N, le Thi Huong D, Combes A, Tieuli\u00e9 N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus. 2008;17(2):139\u201347. https:\/\/doi.org\/10.1177\/0961203307085405.","journal-title":"Lupus"},{"issue":"4","key":"5119_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4103\/0028-3886.55571","volume":"57","author":"N Dilek","year":"2009","unstructured":"Dilek N, Gulay K, Emel E, Forta H. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Neurol India. 2009;57(4):497\u201399. https:\/\/doi.org\/10.4103\/0028-3886.55571.","journal-title":"Neurol India"},{"issue":"2","key":"5119_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0961203309345749","volume":"19","author":"AK Bag","year":"2010","unstructured":"Bag AK, Cur\u00e9 JK, Sullivan JC, Roberson GH. Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations? Lupus. 2010;19(2):225\u201326. https:\/\/doi.org\/10.1177\/0961203309345749.","journal-title":"Lupus"},{"key":"5119_CR18","doi-asserted-by":"publisher","unstructured":"Chen HA, Lin YJ, Chen PC, Chen TY, Lin KC, Cheng HH. Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy. Int J Rheum Dis. 2010;13(4). https:\/\/doi.org\/10.1111\/j.1756-185X.2010.01545.x.","DOI":"10.1111\/j.1756-185X.2010.01545.x"},{"issue":"2","key":"5119_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10157-010-0380-2","volume":"15","author":"K Ishikura","year":"2011","unstructured":"Ishikura K, Hamasaki Y, Sakai T, Hataya H, Goto T, Miyama S, et al. Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol. 2011;15(2):275\u201380. https:\/\/doi.org\/10.1007\/s10157-010-0380-2.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"5119_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.semarthrit.2011.07.001","volume":"41","author":"CE Barber","year":"2011","unstructured":"Barber CE, Leclerc R, Gladman DD, Urowitz MB, Fortin PR. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Semin Arthritis Rheumatism. 2011;41(3):353\u201363. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.07.001.","journal-title":"Semin Arthritis Rheumatism"},{"issue":"1","key":"5119_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3899\/jrheum.110838","volume":"39","author":"C Monteiro","year":"2012","unstructured":"Monteiro C, Almeida I, Dias D, Santos E. Atypical posterior reversible encephalopathy syndrome: a flare of systemic lupus erythematosus: figure 1. J Rheumatol. 2012;39(1):195\u201396. https:\/\/doi.org\/10.3899\/jrheum.110838.","journal-title":"J Rheumatol"},{"issue":"12","key":"5119_CR22","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1007\/s00296-012-2476-3","volume":"32","author":"A Dhillon","year":"2012","unstructured":"Dhillon A, Velazquez C, Siva C. Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature. Rheumatol Int. 2012;32(12):3707\u201313. https:\/\/doi.org\/10.1007\/s00296-012-2476-3.","journal-title":"Rheumatol Int"},{"issue":"5","key":"5119_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/0961203313478303","volume":"22","author":"SS Shaharir","year":"2013","unstructured":"Shaharir SS, Remli R, Marwan AA, Said MSM, Kong NCT. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases. Lupus. 2013;22(5):492\u201396. https:\/\/doi.org\/10.1177\/0961203313478303.","journal-title":"Lupus"},{"issue":"6","key":"5119_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/RHU.0b013e3182a21ffd","volume":"19","author":"N Gatla","year":"2013","unstructured":"Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19(6):334\u201340. https:\/\/doi.org\/10.1097\/RHU.0b013e3182a21ffd.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"5119_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/1756-185X.12148","volume":"16","author":"S Chennareddy","year":"2013","unstructured":"Chennareddy S, Adapa R, Kishore BKV, Rajasekhar L. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases. Int J Rheum Dis. 2013;16(6):786\u201388. https:\/\/doi.org\/10.1111\/1756-185X.12148.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"5119_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5414\/NP300771","volume":"34","author":"C Jacquot","year":"2015","unstructured":"Jacquot C, Glastonbury CM, Tihan T. Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution. NP. 2015;34(1):26\u201333. https:\/\/doi.org\/10.5414\/NP300771.","journal-title":"NP"},{"key":"5119_CR27","doi-asserted-by":"publisher","unstructured":"Jabrane M, Lahcen ZA, Fadili W, Laouad I. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide. Rheumatol Int. 2015;35(5):935-938. https:\/\/doi.org\/10.1007\/s00296-014-3173-1.","DOI":"10.1007\/s00296-014-3173-1"},{"issue":"4","key":"5119_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5152\/TJAR.2015.13540","volume":"43","author":"ZI Arslan","year":"2015","unstructured":"Arslan ZI, Turna CK, \u00d6zerdem CY, Yavuz S, Baykara N, Solak M. Treatment of posterior reversible encephalopathy syndrome that occurred in a patient with systemic lupus erythematosus by plasmapheresis. Turk J Anaesth Reanim. 2015;43(4):291\u201394. https:\/\/doi.org\/10.5152\/TJAR.2015.13540.","journal-title":"Turk J Anaesth Reanim"},{"key":"5119_CR29","doi-asserted-by":"crossref","unstructured":"Khajuria B, Khajuria M, Agrawal Y. Mycophenolate-induced posterior reversible encephalopathy syndrome. 2015. www.americantherapeutics.com.","DOI":"10.1097\/MJT.0000000000000270"},{"issue":"12","key":"5119_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1177\/0961203316643598","volume":"25","author":"TS Ferreira","year":"2016","unstructured":"Ferreira TS, Reis F, Appenzeller S. Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus. Lupus. 2016;25(12):1369\u201376. https:\/\/doi.org\/10.1177\/0961203316643598.","journal-title":"Lupus"},{"key":"5119_CR31","doi-asserted-by":"publisher","unstructured":"Zeki\u0107 T, Beni\u0107 MS, Antulov R, Anton\u010di\u0107 I, Novak S. The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients. Rheumatol Int. 2017;37(12):2105-2114. https:\/\/doi.org\/10.1007\/s00296-017-3843-x.","DOI":"10.1007\/s00296-017-3843-x"},{"issue":"11","key":"5119_CR32","first-page":"700","volume":"19","author":"S Szamosi","year":"2017","unstructured":"Szamosi S, Bodn\u00e1r N, Brug\u00f3s B, Hortob\u00e1gyi T, M\u00e9hes G, Szab\u00f3 Z, et al. Posterior reversible encephalopathy syndrome (PRES) associated with thrombotic thrombocytopenic purpura in a systemic lupus erythematosus patient. IMAJ - Isr Med Assoc J. 2017;19(11):700\u201302.","journal-title":"IMAJ - Isr Med Assoc J"},{"key":"5119_CR33","doi-asserted-by":"publisher","unstructured":"Mustafa KN, Qasem U, Al-Ryalat NT, Bsisu IK. Rituximab-associated posterior reversible encephalopathy syndrome. Int J Rheum Dis. 2019;22(1):160-165. https:\/\/doi.org\/10.1111\/1756-185X.13427.","DOI":"10.1111\/1756-185X.13427"},{"key":"5119_CR34","doi-asserted-by":"publisher","unstructured":"Maier S, Monica C, Romaniuc A, Andone S, B\u0103la\u015fa R. Central-variant posterior reversible encephalopathy syndrome in a young patient with systemic lupus erythematosus. Acta Neurol Belg. 2019;119(2):269-271. https:\/\/doi.org\/10.1007\/s13760-018-1046-1.","DOI":"10.1007\/s13760-018-1046-1"},{"issue":"7","key":"5119_CR35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/ccr3.2245","volume":"7","author":"T Vaysman","year":"2019","unstructured":"Vaysman T, Xu P, Vartanian T, Michalak P, Pike K, Liu A. \u201cHighlighting\u201d red nuclei by atypical posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus. Clin Case Rep. 2019;7(7):1404\u201308. https:\/\/doi.org\/10.1002\/ccr3.2245.","journal-title":"Clin Case Rep"},{"issue":"1","key":"5119_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1148\/radiol.2020181547","volume":"296","author":"P Abraham","year":"2020","unstructured":"Abraham P, Longardner K, Chen P, Huisa B, Handwerker J. Case 279: Central-variant posterior reversible encephalopathy syndrome. Radiology. 2020;296(1):239\u201343. https:\/\/doi.org\/10.1148\/radiol.2020181547.","journal-title":"Radiology"},{"issue":"3","key":"5119_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.31138\/mjr.31.3.358","volume":"31","author":"F Uluta\u015f","year":"2020","unstructured":"Uluta\u015f F, \u00c7obankara V, Karasu U, Baser N, Akbudak IH. A Rare case with systemic lupus erythematosus manifested by two different neurologic Entities; guillain barre syndrome and posterior reversible encephalopathy syndrome. MJR. 2020;31(3):358\u201361. https:\/\/doi.org\/10.31138\/mjr.31.3.358.","journal-title":"MJR"},{"key":"5119_CR38","doi-asserted-by":"publisher","unstructured":"Hao DL, Yang YL, Zhou LM, Liu QH, Liu R, Xu K, et al. Systemic lupus erythematosus complicated with reversible posterior encephalopathy syndrome: a case report. J Int Med Res. 2021;49(7). https:\/\/doi.org\/10.1177\/03000605211029766.","DOI":"10.1177\/03000605211029766"},{"key":"5119_CR39","doi-asserted-by":"publisher","unstructured":"Dai Y, Liu W, Hong F. Post reversible encephalopathy syndrome attributed to mycophenolate mofetil used in the treatment of SLE: a case report and review of literature. J Int Med Res. 2024;52(1). https:\/\/doi.org\/10.1177\/03000605231218620.","DOI":"10.1177\/03000605231218620"},{"issue":"12","key":"5119_CR40","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/ndt\/gfg347","volume":"18","author":"PFK Yong","year":"2003","unstructured":"Yong PFK, Hamour SMA, Burns A. Reversible posterior leukoencephalopathy in a patient with systemic sclerosis\/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transpl. 2003;18(12):2660\u201362. https:\/\/doi.org\/10.1093\/ndt\/gfg347.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5119_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/1752-1947-8-442","volume":"8","author":"JL Jayaweera","year":"2014","unstructured":"Jayaweera JL, Withana MR, Dalpatadu CKP, Beligaswatta CD, Rajapakse T, Jayasinghe S, et al. Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report. J Med Case Rep. 2014;8(1):442. https:\/\/doi.org\/10.1186\/1752-1947-8-442.","journal-title":"J Med Case Rep"},{"key":"5119_CR42","doi-asserted-by":"publisher","unstructured":"Tabot Tabot MK, Ababio PA, Waldron S, Rougui L, Mehari A. A Rare case of cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with acute lupus nephritis flare. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.34372.","DOI":"10.7759\/cureus.34372"},{"key":"5119_CR43","doi-asserted-by":"publisher","unstructured":"Chen B, Hong H, Wang J, Li X, Wang C, Xie T. Systemic lupus erythematosus with recurrent posterior reversible encephalopathy syndrome: a rare case report. Med (U States). 2025;104(29):e43428. https:\/\/doi.org\/10.1097\/MD.0000000000043428.","DOI":"10.1097\/MD.0000000000043428"},{"issue":"1","key":"5119_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0961203315607648","volume":"24","author":"S Mondal","year":"2015","unstructured":"Mondal S, Goswami RP, Sinha D, Basu K, Das S, Ghosh P, et al. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender. Lupus. 2015;24(1):1\u20132. https:\/\/doi.org\/10.1177\/0961203315607648.","journal-title":"Lupus"},{"key":"5119_CR45","doi-asserted-by":"publisher","unstructured":"Ho CM, Mok CC. Posterior reversible encephalopathy syndrome as a neuropsychiatric manifestation of systemic lupus erythematosus. Hong Kong Med J. 2019;25(5):410-412. https:\/\/doi.org\/10.12809\/hkmj187579.","DOI":"10.12809\/hkmj187579"},{"issue":"3","key":"5119_CR46","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.radcr.2024.11.070","volume":"20","author":"PK Sharma","year":"2025","unstructured":"Sharma PK, Balachandar S, Vikram MA, Sukumar PD. Rituximab (monoclonal anti-CD20 antibody) induced posterior reversible encephalopathy syndrome (PRES): a case report and literature review. Radiol Case Rep. 2025;20(3):1538\u201347. https:\/\/doi.org\/10.1016\/j.radcr.2024.11.070.","journal-title":"Radiol Case Rep"},{"issue":"3","key":"5119_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.rhu.0000164825.63063.43","volume":"11","author":"KC Shin","year":"2005","unstructured":"Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. JCR: J Clin Rheumatol. 2005;11(3):164\u201366. https:\/\/doi.org\/10.1097\/01.rhu.0000164825.63063.43.","journal-title":"JCR: J Clin Rheumatol"},{"key":"5119_CR48","unstructured":"Lai T, Wong T, Wong W, Chin A, Chan R, Huang H. A reversible cause of blindness that should not Be forgotten: cyclosporine-induced posterior reversible encephalopathy syndrome. 2009. www.hkmj.org."},{"issue":"1","key":"5119_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0009922810378736","volume":"50","author":"J Golden","year":"2011","unstructured":"Golden J, Heacock L, Boonyasampant M, Chiechi MV, Koppel B, Inamdar S. Posterior reversible encephalopathy syndrome in a 13-year-old female with mild systemic lupus erythematosus. Clin Pediatr (Phila). 2011;50(1):76\u201378. https:\/\/doi.org\/10.1177\/0009922810378736.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"5119_CR50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/hep.510240414","volume":"24","author":"LD Deleve","year":"1996","unstructured":"Deleve LD. Cellular Target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation SEC were seeded on collagen-coated inserts for 24-well plates. Hepatology. 1996;24(4):830\u201337. https:\/\/doi.org\/10.1002\/hep.510240414.","journal-title":"Hepatology"},{"issue":"7","key":"5119_CR51","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3174\/ajnr.A0549","volume":"28","author":"WS Bartynski","year":"2007","unstructured":"Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320\u201327. https:\/\/doi.org\/10.3174\/ajnr.A0549.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"5119_CR52","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2214\/AJR.07.2024","volume":"189","author":"AM McKinney","year":"2007","unstructured":"McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol. 2007;189(4):904\u201312. https:\/\/doi.org\/10.2214\/AJR.07.2024.","journal-title":"Am J Roentgenol"},{"issue":"9","key":"5119_CR53","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. The Lancet Neurol. 2015;14(9):914\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(15)00111-8.","journal-title":"The Lancet Neurol"},{"issue":"5","key":"5119_CR54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3174\/ajnr.A2886","volume":"33","author":"AM McKinney","year":"2012","unstructured":"McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2012;33(5):896\u2013903. https:\/\/doi.org\/10.3174\/ajnr.A2886.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"5119_CR55","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3174\/ajnr.A1588","volume":"30","author":"HM Hefzy","year":"2009","unstructured":"Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30(7):1371\u201379. https:\/\/doi.org\/10.3174\/ajnr.A1588.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"5119_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.46497\/ArchRheumatol.2023.41875","volume":"38","author":"A Bahar Kele\u015fo\u011flu Din\u00e7er","year":"2023","unstructured":"Bahar Kele\u015fo\u011flu Din\u00e7er A, Erkan D. The ABCs of antiphospholipid syndrome. Archives Rheumatol. 2023;38(2):163\u201373. https:\/\/doi.org\/10.46497\/ArchRheumatol.2023.41875.","journal-title":"Archives Rheumatol"},{"key":"5119_CR57","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3389\/fphys.2018.01840","volume":"9","author":"M Vel\u00e1squez","year":"2018","unstructured":"Vel\u00e1squez M, Rojas M, Abrahams VM, Escudero C, Cadavid \u00c1P. Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations. Front. Physiol. 2018;9:1840. https:\/\/doi.org\/10.3389\/fphys.2018.01840.","journal-title":"Front. Physiol"},{"issue":"3","key":"5119_CR58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semarthrit.2005.05.006","volume":"35","author":"KD Deane","year":"2005","unstructured":"Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheumatism. 2005;35(3):154\u201365. https:\/\/doi.org\/10.1016\/j.semarthrit.2005.05.006.","journal-title":"Semin Arthritis Rheumatism"},{"issue":"10","key":"5119_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-019-0852-7","volume":"21","author":"SA Stoots","year":"2019","unstructured":"Stoots SA, Lief L, Erkan D. Clinical insights into diffuse alveolar hemorrhage in antiphospholipid syndrome. Curr Rheumatol Rep. 2019;21(10):56. https:\/\/doi.org\/10.1007\/s11926-019-0852-7.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"5119_CR60","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","volume":"44","author":"ME de Jonge","year":"2005","unstructured":"de Jonge ME, Huitema ADR, Rodenhuis S, Beijnen JH. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet. 2005;44(11):1135\u201364. https:\/\/doi.org\/10.2165\/00003088-200544110-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"5119_CR61","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2125.2012.04223.x","volume":"74","author":"MS Joy","year":"2012","unstructured":"Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, et al. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Brit J Clin Pharma. 2012;74(3):445\u201355. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04223.x.","journal-title":"Brit J Clin Pharma"},{"issue":"3","key":"5119_CR62","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/art.39938","volume":"69","author":"H Meng","year":"2017","unstructured":"Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, et al. In vivo role of neutrophil extracellular traps in antiphospholipid antibody\u2013mediated venous thrombosis. Arthritis Rheumatol. 2017;69(3):655\u201367. https:\/\/doi.org\/10.1002\/art.39938.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"5119_CR63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530\u201334. https:\/\/doi.org\/10.1191\/0961203303lu394oa.","journal-title":"Lupus"},{"issue":"1","key":"5119_CR64","first-page":"1","volume":"7","author":"L Zhang","year":"2018","unstructured":"Zhang L, Xu J. Case report posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review. Am J Clin Exp Immunol. 2018;7(1):1\u20137. www.ajcei.us\/.","journal-title":"Am J Clin Exp Immunol"},{"issue":"12","key":"5119_CR65","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/08830738050200121201","volume":"20","author":"H Ozyurek","year":"2005","unstructured":"Ozyurek H, Oguz G, Ozen S, Akyuz C, Oguz KK, Anlar B, et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005;20(12):990\u201393. https:\/\/doi.org\/10.1177\/08830738050200121201.","journal-title":"J Child Neurol"},{"issue":"1","key":"5119_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000103618","volume":"24","author":"D Renard","year":"2007","unstructured":"Renard D, Dutray A, le Quellec A, Milhaud D. Reversible posterior leukoencephalopathy syndrome in catastrophic antiphospholipid syndrome. Cerebrovasc Dis. 2007;24(1):141\u201343. https:\/\/doi.org\/10.1159\/000103618.","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"5119_CR67","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/art.27471","volume":"62","author":"P Efthimiou","year":"2010","unstructured":"Efthimiou P, Kukar M, Krishnan P. Clinical image: posterior reversible encephalopathy syndrome as a severe manifestation of neuropsychiatric systemic lupus erythematosus. Arthritis Rheumatism. 2010;62(6):1692. https:\/\/doi.org\/10.1002\/art.27471.","journal-title":"Arthritis Rheumatism"},{"key":"5119_CR68","doi-asserted-by":"publisher","unstructured":"Maeda H, Nasu M, and Sakai S. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus with anti-phospholipid antibodies treated by plasma exchange: a case report. Ther Apher Dial. 2011;15(4):415\u201316. https:\/\/doi.org\/10.1111\/j.1744-9987.2011.00972.x.","DOI":"10.1111\/j.1744-9987.2011.00972.x"},{"key":"5119_CR69","unstructured":"Sulaiman W, Mat Husin N, Shafie Baba M. Oman Medical specialty board posterior reversible encephalopathy in Undiagnosed systemic lupus erythematous: a case report. Med J. 2011;26(6)."},{"key":"5119_CR70","doi-asserted-by":"publisher","unstructured":"Bhavsar SV, White CM, Fifi-Mah A. A fulminant neurologic presentation of systemic lupus erythematosus. Int J Rheum Dis. 2012;15(2). https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01663.x.","DOI":"10.1111\/j.1756-185X.2011.01663.x"},{"issue":"10","key":"5119_CR71","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1177\/0961203312444171","volume":"21","author":"MU Mart\u00ednez-Mart\u00ednez","year":"2012","unstructured":"Mart\u00ednez-Mart\u00ednez MU, Abud-Mendoza C. Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab. Lupus. 2012;21(10):1124\u201327. https:\/\/doi.org\/10.1177\/0961203312444171.","journal-title":"Lupus"},{"issue":"5","key":"5119_CR72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/RHU.0b013e318262249b","volume":"18","author":"HK Grewal","year":"2012","unstructured":"Grewal HK, Saketkoo LA, Garcia-Valladares I, Espinoza LR. Central nervous system involvement including visual loss in a patient with systemic lupus erythematosus with posterior reversible leukoencephalopathy syndrome. JCR: J Clin Rheumatol. 2012;18(5):263\u201364. https:\/\/doi.org\/10.1097\/RHU.0b013e318262249b.","journal-title":"JCR: J Clin Rheumatol"},{"issue":"12","key":"5119_CR73","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10072-013-1479-5","volume":"34","author":"Q Li","year":"2013","unstructured":"Li Q, Lv F, Wei Y, Yan B, Xie P. Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone. Neurol. Sci. 2013;34(12):2241\u201342. https:\/\/doi.org\/10.1007\/s10072-013-1479-5.","journal-title":"Neurol. Sci"},{"key":"5119_CR74","doi-asserted-by":"publisher","unstructured":"Chan DYS, Ong YS. Posterior reversible encephalopathy syndrome: an acute manifestation of systemic lupus erythematous. smedj. 2013;54(9):e193\u201395. https:\/\/doi.org\/10.11622\/smedj.2013182.","DOI":"10.11622\/smedj.2013182"},{"issue":"3","key":"5119_CR75","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/1756-185X.12235","volume":"17","author":"S Sato","year":"2014","unstructured":"Sato S, Nakajima J, Shimura M, Kawashima H, Yoshio T, Hara Y. Reversible basal ganglia lesions in neuropsychiatric lupus: a report of three pediatric cases. Int J Rheum Dis. 2014;17(3):274\u201379. https:\/\/doi.org\/10.1111\/1756-185X.12235.","journal-title":"Int J Rheum Dis"},{"key":"5119_CR76","doi-asserted-by":"publisher","unstructured":"Ungprasert P. An uncommon cause of alteration of consciousness in a patient with systemic lupus erythematosus. Am J Emerg Med. 2014;32(9):.e1155.1\u201352. https:\/\/doi.org\/10.1016\/j.ajem.2014.02.040.","DOI":"10.1016\/j.ajem.2014.02.040"},{"issue":"9","key":"5119_CR77","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.braindev.2016.03.011","volume":"38","author":"A Nasri","year":"2016","unstructured":"Nasri A, Bedoui I, Mrissa R, Riahi A, Derbali H, Zaouali J, et al. Recurrent status epilepticus in posterior reversible encephalopathy syndrome as initial feature of pediatric lupus: a newly diagnosed case and literature review. Brain Devel. 2016;38(9):835\u201341. https:\/\/doi.org\/10.1016\/j.braindev.2016.03.011.","journal-title":"Brain Devel"},{"issue":"3","key":"5119_CR78","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5606\/ArchRheumatol.2017.6124","volume":"32","author":"X Song","year":"2017","unstructured":"Song X, Rong X, Liu Y. An atypical syndrome in an elderly patient with systemic lupus erythematosus, sj\u00f6gren syndrome, and primary biliary cirrhosis. Archives Rheumatol. 2017;32(3):250\u201352. https:\/\/doi.org\/10.5606\/ArchRheumatol.2017.6124.","journal-title":"Archives Rheumatol"},{"key":"5119_CR79","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Grimshaw M, Dom\u00ednguez-Moreno R, Vald\u00e9s-Ferrer SI. Posterior reversible encephalopathy syndrome: an underrecognized manifestation of systemic lupus erythematosus. Neurohospitalist. 2020;10(3):234-235. https:\/\/doi.org\/10.1177\/1941874419889467.","DOI":"10.1177\/1941874419889467"},{"key":"5119_CR80","doi-asserted-by":"publisher","unstructured":"Hartman EN, Tuna K, Monsour E, Komanduri K, Tarasiuk-Rusek A. Seizure as an initial presentation for posterior reversible encephalopathy syndrome in Undiagnosed systemic lupus erythematosus and lupus nephritis: a case report. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.10195.","DOI":"10.7759\/cureus.10195"},{"key":"5119_CR81","doi-asserted-by":"publisher","unstructured":"de Medeiros FC, Rocha Sousa BM, Cruz Santos DN, Novais Matias Sion G, Fontes Alves C. Posterior reversible encephalopathy syndrome as the first clinical manifestation of lupus nephritis. In: Acta Neurologica Belgica. Vol. 122 (1). Springer Science and Business Media Deutschland GmbH; 2022. p. 219\u201321. https:\/\/doi.org\/10.1007\/s13760-021-01614-4.","DOI":"10.1007\/s13760-021-01614-4"},{"key":"5119_CR82","doi-asserted-by":"publisher","unstructured":"Jesrani G, Gupta S, Arya Y, Syal A, Gupta M. Systemic lupus erythematosus induced Central variant of posterior reversible encephalopathy syndrome: a Rare association. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.13431.","DOI":"10.7759\/cureus.13431"},{"key":"5119_CR83","doi-asserted-by":"publisher","unstructured":"Khalid Rafat W, Sarmast ST, Shiza ST, Olaleye K, Rogers S. Posterior reversible encephalopathy in Undiagnosed systemic lupus erythematosus: a Rare case report. 2021. https:\/\/doi.org\/10.7759\/cureus.16945. Cureus.","DOI":"10.7759\/cureus.16945"},{"key":"5119_CR84","doi-asserted-by":"publisher","unstructured":"Gros C, Fogel O, Boudhabhay I, Debiais C, Duong Van Huyen JP, Hummel A, et al. Challenging diagnosis of renal failure associated with severe neurological symptoms in a patient with mixed connective tissue disease. J Educ Chang Scleroderma Relat Disord. 2023;8(1):NP6\u201310. https:\/\/doi.org\/10.1177\/23971983221099847.","DOI":"10.1177\/23971983221099847"},{"issue":"3","key":"5119_CR85","doi-asserted-by":"publisher","first-page":"391","DOI":"10.31138\/mjr.20230905.tc","volume":"34","author":"Y Ozturk","year":"2023","unstructured":"Ozturk Y, Ozturk N, Argun A, Ozer H, Yonet F, Baloglu \u0130. Tonic-clonic seizure in patient with SLE: posterior reversible encephalopathy syndrome, or a neuropsychiatric manifestation of SLE? MJR. 2023;34(3):391\u201395. https:\/\/doi.org\/10.31138\/mjr.20230905.tc.","journal-title":"MJR"},{"issue":"3","key":"5119_CR86","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s13730-025-00973-8","volume":"14","author":"Y Kadoh","year":"2025","unstructured":"Kadoh Y, Yoshino J, Oka T, Itoga K, Hanada M, Niino D, et al. A case of posterior and reversible encephalopathy syndrome in a patient previously undiagnosed with lupus nephritis. CEN Case Rep. 2025;14(3):328\u201334. https:\/\/doi.org\/10.1007\/s13730-025-00973-8.","journal-title":"CEN Case Rep"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05119-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05119-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05119-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:39:27Z","timestamp":1790725167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05119-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5119"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05119-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present work was conducted in accordance with the Declaration of Helsinki. This study is a case report with a literature review; therefore, approval by an ethics committee was not required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the patient is deceased, written informed consent for publication of this case report was obtained from the next of kin.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"572"}}